Solvonis Therapeutics (formerly Awakn) Email Formats

Biotechnology Research • London, England, United Kingdom • 1-10 Employees

Key Contact at Solvonis Therapeutics (formerly Awakn)

Rebecca Protheroe

Clinic Director

Company overview

Headquarters	London, England, United Kingdom
Phone number	+444169075644
Website	solvonis.com
NAICS	541714
Keywords	Biotechnology, Addiction, Alcohol Use Disorder, Clinical Stage
Founded	2020
Employees	1-10
Socials

About Solvonis Therapeutics (formerly Awakn)

Solvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing innovative medicines for addiction and mental health disorders. Headquartered in London and listed on the London Stock Exchange main market, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need. The company’s current focus is on Alcohol Use Disorder (AUD)—affecting over 40 million people across the U.S., UK, and EU4—and Post-Traumatic Stress Disorder (PTSD), which impacts more than 13 million adults in the U.S. and approximately 20 million across the same regions.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore Solvonis Therapeutics (formerly Awakn)'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-05-26	14	$2,000,000
2024-03-03	14	$97,500
2024-05-19	14	$812,200
2025-01-18	16	$535,000

Funding Insights

$3,444,700

Total funding amount

$535,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Solvonis Therapeutics (formerly Awakn) is located in London, England, GB.

You can reach Solvonis Therapeutics (formerly Awakn) at +444169075644.

Solvonis Therapeutics (formerly Awakn) was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Solvonis Therapeutics (formerly Awakn) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Solvonis Therapeutics (formerly Awakn) has raised a total of $3,444,700 across 4 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Solvonis Therapeutics (formerly Awakn)

Rebecca Protheroe

Clinic Director

4.8

40,000 users